Related Experiment Video
Updated: May 31, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
Protective role of IL-33/ST2 axis in Con A-induced hepatitis
Vladislav Volarevic1, Marina Mitrovic, Marija Milovanovic
1Department of Microbiology and Immunology, Centre for Molecular Medicine and Stem Cell Research, Faculty of Medicine, University of Kragujevac, Serbia.
Background & Aims:
We used Concanavalin A-induced liver injury to study the role of Interleukin 33 and its receptor ST2 in the induction of inflammatory pathology and hepatocellular damage.
Methods:
We tested susceptibility to Concanavalin A induced hepatitis in ST2 deficient and wild type BALB/c mice and analyzed the effects of single injection of Interleukin 33 as evaluated by liver enzyme test, quantitative histology, mononuclear cell infiltration, cytokine production, intracellular staining of immune cells, and markers of apoptosis in the liver.
Results:
ST2 deficient mice developed significantly more severe hepatitis and had significantly higher number of mononuclear cells in the liver, CD4+ and CD8+ T cells, NKp46+ and CD3+NKp46+ cells, and F4/80+ macrophages. The level of pro-inflammatory cytokines in the sera and number of TNF alpha, IFN gamma, and IL-17 producing cells was higher in ST2 deficient mice. In contrast, number of CD4+Foxp3+ cells was statistically higher in wild type mice. Additionally, treatment of wild type mice with single (1 μg) injection of Interleukin 33 led to attenuation of the liver injury and milder infiltration of mononuclear cells, increase in total number of liver CD4+Foxp3+ cells and IL-4 producing CD4+ T cells. Interleukin 33 also suppressed the activation of caspase 3, prevented the expression of BAX, and enhanced the expression of antiapoptotic Bcl-2 in the liver.
Conclusions:
We concluded that Interleukin 33/ST2 axis downregulated Concanavalin A-induced liver injury and should be evaluated as potential target in fulminant hepatitis in humans.
Insights
The Interleukin 33/ST2 pathway protects against Concanavalin A-induced liver injury by reducing inflammation and hepatocellular damage. This suggests the Interleukin 33/ST2 axis is a potential therapeutic target for fulminant hepatitis.
Area of Science:
- Immunology
- Hepatology
- Inflammation research
Background:
- Concanavalin A (ConA) induces liver injury, serving as a model for hepatitis.
- Interleukin 33 (IL-33) and its receptor ST2 play roles in immune responses and inflammation.
- The specific role of the IL-33/ST2 axis in ConA-induced liver injury requires further elucidation.
Purpose of the Study:
- To investigate the function of the IL-33/ST2 axis in ConA-induced liver injury.
- To determine the impact of IL-33/ST2 signaling on inflammatory pathology and hepatocellular damage.
Main Methods:
- Comparison of ConA-induced hepatitis severity in ST2-deficient and wild-type mice.
- Analysis of liver enzymes, histology, immune cell infiltration (including T cells, NK cells, and macrophages), cytokine production, and apoptosis markers.
- Assessment of the effects of exogenous IL-33 administration in wild-type mice.
Main Results:
- ST2-deficient mice exhibited exacerbated hepatitis with increased inflammatory cell infiltration and higher levels of pro-inflammatory cytokines (TNF-α, IFN-γ, IL-17).
- Wild-type mice showed higher numbers of regulatory T cells (CD4+Foxp3+).
- IL-33 administration attenuated liver injury, reduced inflammation, promoted regulatory T cell expansion, and modulated apoptosis-related proteins (caspase 3, BAX, Bcl-2).
Conclusions:
- The IL-33/ST2 axis plays a protective role by downregulating ConA-induced liver injury.
- Targeting the IL-33/ST2 pathway may offer a therapeutic strategy for fulminant hepatitis.
Related Concept Videos
Hepatitis
Cirrhosis II: Pathophysiology
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Gastritis II: Pathophysiology
Inflammatory Bowel Disease II: Ulcerative Colitis
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
